Open AccessAscites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging
Author(s) -
Asmaa Gomaa
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i18.5654
Subject(s) - ascites , medicine , hepatocellular carcinoma , gastroenterology , cirrhosis , liver cancer , liver disease , alpha fetoprotein , hepatic encephalopathy , stage (stratigraphy) , biology , paleontology
To assess how ascites and alpha-fetoprotein (AFP) added to the Barcelona Clinic Liver Cancer (BCLC) staging predict hepatocellular carcinoma survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom